医学
长春新碱
美罗华
危险系数
内科学
切碎
弥漫性大B细胞淋巴瘤
胃肠病学
置信区间
临床终点
环磷酰胺
强的松
安慰剂
外科
作者
Hervé Tilly,Franck Morschhauser,Laurie H. Sehn,Jonathan W. Friedberg,Marek Trnený,Jeff P. Sharman,Charles Herbaux,John M. Burke,Matthew Matasar,Shinya Rai,Koji Izutsu,Neha Mehta-Shah,Lucie Oberic,Adrien Chauchet,Wojciech Jurczak,Yuqin Song,Richard Greil,Larysa Mykhalska,Juan M Bergua-Burgués,Matthew C. Cheung
标识
DOI：10.1056/nejmoa2115304
摘要
Among patients with previously untreated intermediate-risk or high-risk DLBCL, the risk of disease progression, relapse, or death was lower among those who received pola-R-CHP than among those who received R-CHOP. (Funded by F. Hoffmann-La Roche/Genentech; POLARIX ClinicalTrials.gov number, NCT03274492.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Criminology34
清飏
lsl
ccm
方汀
无极微光
哈哈
tuanheqi
米粉好好吃
轨迹
舒心凡
乐空思
null
CodeCraft
VDC
嘿嘿
浮游
寻道图强
ShmilyLJQ
MchemG
走啊走
优美紫槐
xu
dawnfrf
皖公网安备34019202002308
